Fatima, S.; Ma, Y.; Safrachi, A.; Haider, S.; Spring, K.J.; Vafaee, F.; Scott, K.F.; Roberts, T.L.; Becker, T.M.; de Souza, P.
Harnessing Liquid Biopsies to Guide Immune Checkpoint Inhibitor Therapy. Cancers 2022, 14, 1669.
https://doi.org/10.3390/cancers14071669
AMA Style
Fatima S, Ma Y, Safrachi A, Haider S, Spring KJ, Vafaee F, Scott KF, Roberts TL, Becker TM, de Souza P.
Harnessing Liquid Biopsies to Guide Immune Checkpoint Inhibitor Therapy. Cancers. 2022; 14(7):1669.
https://doi.org/10.3390/cancers14071669
Chicago/Turabian Style
Fatima, Shadma, Yafeng Ma, Azadeh Safrachi, Sana Haider, Kevin J. Spring, Fatemeh Vafaee, Kieran F. Scott, Tara L. Roberts, Therese M. Becker, and Paul de Souza.
2022. "Harnessing Liquid Biopsies to Guide Immune Checkpoint Inhibitor Therapy" Cancers 14, no. 7: 1669.
https://doi.org/10.3390/cancers14071669
APA Style
Fatima, S., Ma, Y., Safrachi, A., Haider, S., Spring, K. J., Vafaee, F., Scott, K. F., Roberts, T. L., Becker, T. M., & de Souza, P.
(2022). Harnessing Liquid Biopsies to Guide Immune Checkpoint Inhibitor Therapy. Cancers, 14(7), 1669.
https://doi.org/10.3390/cancers14071669
